Tracking forecast, no surprises in 2Q Valuations increasingly attractive for long-term investment Solid 1Q; Outlook getting better HANG LUNG PROPERTIES ALERT(0101.HK):UNDERLYING NET PROFIT -1% YOY DUE TO NEW MALLS AND LOWER MARGIN Huahai generic drug tracker (6): Lamo ER’s US market share at 32% in 2Q15 Buy: Feedback from 2Q15 investor lunch COMPANY / INDUSTRY NEWS Regional Morning Notes China Life Insurance Expects Net Up by 70% on Strong Investment Income Greater China Textile：TPP deep-dive: No major benefits before 2017; Sell Eclat